The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

CBSE Class 12 Board Exams 2026:The Chemistry paper will be held on February 28. CBSE Class 12 Board Exams 2026: The Chemistry paper is considered one of the most challenging in the Class 12 board ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Abstract: Computer science is becoming ever increasingly important to our society. Computer science content has, however, not traditionally been considered a natural part of curricula for primary and ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

While preparing the date sheet, CBSE ensured sufficient gaps between two subjects generally offered by a student. The timetable also accounts for entrance examinations for Class 12 students, allowing ...

NEW DELHI: The Centre has entrusted the National Council of Educational Research and Training (NCERT) with the responsibility of granting certificates equivalent to that of the Secondary (Class 10) ...

The Central Board of Secondary Education (CBSE) has released the tentative date sheets for the 2026 Board Examinations for Classes X and XII, to be held from February 17, 2026, to July 15, 2026. The ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Recursion Pharmaceuticals, Inc. is one of them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with ...